Patents by Inventor Vinod Singh

Vinod Singh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210273638
    Abstract: The present invention related to a universal semiconductor switch. In one embodiment, the switch includes a switching arrangement having an input power connection configured as input for a solid state switching device, the solid state switching device operationally coupled to a current limiting arrangement and an output circuit; the output circuit including a filter circuit. At least one trigger circuit including a power source and an on-and-off circuit, said trigger circuit operably coupled to the switching arrangement input power source and the solid state switching device. An on-command noise immunity circuit and an off-command noise immunity circuit are operationally coupled to the trigger circuit to suppress the noise from any external source, the switch will trigger only if the detected voltage is beyond the threshold voltage and for a predetermined duration.
    Type: Application
    Filed: May 17, 2021
    Publication date: September 2, 2021
    Inventors: Bhoopendrakumar Singh, Vinod Chippalkatti, Kanthimathinathan Thirugnanam, Sukumar Patil
  • Publication number: 20210266635
    Abstract: A method and system are disclosed for capturing observations of customer-premise equipment or customer-provided equipment (CPE) devices. The method includes reporting a problem detect by a user during use of a customer-premise equipment or customer-provided equipment (CPE) device with one or more specific buttons on a remote controller; and entering the problem into a log with a timestamp.
    Type: Application
    Filed: February 4, 2021
    Publication date: August 26, 2021
    Applicant: ARRIS Enterprises LLC
    Inventors: Virendra SINGH, Murali S. SAHASRANAMAN, Vinod JATTI
  • Patent number: 11098037
    Abstract: The present invention relates to a process for preparing the Alectinib or a pharmaceutically acceptable salt thereof using lesser reaction steps and also eliminating expensive and time-consuming column chromatography. The invention also relates to novel polymorphic forms of Alectinib and Alectinib hydrochloride.
    Type: Grant
    Filed: July 4, 2018
    Date of Patent: August 24, 2021
    Assignee: Fresenius Kabi Oncology Ltd.
    Inventors: Vinod Singh Tomar, Abul Azim, Nitin Gupta, Saswata Lahiri, Walter Cabri
  • Publication number: 20210232818
    Abstract: A method comprising receiving a first set of aerial images of a geographic area, receiving locations of assets, determining a likely location of at least one asset within each image, creating one or more bounding boxes, encompassing the likely location of one or more assets within each of the images, providing any number of the images to a convolutional neural network to classify pixels, the classification of each of the pixels indicating if the pixels are part of one or more obstructions or are part of a different classification, determining at least one zone, the zone encompassing the at least one asset, determining a distance between at least one pixel part of an obstruction and the zone, generating a criticality score based on the distance, comparing the criticality score to a threshold, and providing an alert of a future hazardous condition based on the criticality score.
    Type: Application
    Filed: January 27, 2021
    Publication date: July 29, 2021
    Inventors: Rahul Saxena, Nitin Das, Abhishek Vinod Singh
  • Publication number: 20200140427
    Abstract: The present invention relates to a process for preparing the Alectinib or a pharmaceutically acceptable salt thereof using lesser reaction steps and also eliminating expensive and time-consuming column chromatography. The invention also relates to novel polymorphic forms of Alectinib and Alectinib hydrochloride.
    Type: Application
    Filed: July 4, 2018
    Publication date: May 7, 2020
    Applicant: FRESENIUS KABI ONCOLOGY LIMITED
    Inventors: Vinod Singh TOMAR, Abul AZIM, Nitin GUPTA, Saswata LAHIRI, Walter CABRI
  • Patent number: 9643932
    Abstract: The present invention relates to an improved process for the synthesis of bendamustine, in particular, bendamustine hydrochloride of the formula (VI) and its intermediate 1-methyl-5-[bis(2-chloroethyl)amino]-1H-benzimidazol-2-yl]lithium butanoate of formula (V), both having a purity of ?99%, which is simple, convenient, economical, does not use hazardous chemicals and is industrially viable.
    Type: Grant
    Filed: December 19, 2014
    Date of Patent: May 9, 2017
    Assignee: Fresenius Kabi Oncology Limited
    Inventors: Bhuwan Bhaskar Mishra, Nikunj Shambhubhai Kachhadia, Vinod Singh Tomar, Saswata Lahiri
  • Patent number: 9147349
    Abstract: A system and method for displaying a first intruder aircraft symbology on a lateral map display and on a vertical situation display is provided. Symbology is generated that is graphically representative of the first intruder aircraft on the lateral map display and the VSD. Additional symbology is generated to correlate the first intruder aircraft on the lateral map display to that on the vertical situation display.
    Type: Grant
    Filed: October 12, 2012
    Date of Patent: September 29, 2015
    Assignee: HONEYWELL INTERNATIONAL INC.
    Inventors: Shivashankar Veerayya Maddanimath, Vinod Singh, Satish Pindikoor, Devesh Choubey
  • Publication number: 20150259364
    Abstract: The present invention provides process for preparation of crystalline Bortezomib (Ia) as its monohydrate which is designated as crystalline Form-SB and characterized by having water content ranging between 3.5-6.0% w/w; X-ray powder diffraction pattern comprising characteristic 20° peaks selected from the XRPD peak set of 5.6, 7.5, 9.8, 10.2, 11.3, 15.1, 18.0, 20.5, 21.5 and 23.6±0.20 2?°, wherein peaks at 9.8 and 11.39±0.20 2?° are un-split and 100% intensity peak is present at 5.6±0.20 2?°, DSC isotherm comprising the endothermic peaks ranging between 45 to 60° C. (Peak-1) and 175 to 185° C. (Peak-2) and IR absorption characteristic peaks approximately at 3387 cm?1, 3304 cm?1, 2953 cm?1, 2927 cm?1, 2868 cm?1, 1627 cm?1, 1455 cm?1, 1400 cm?1, 1201 cm?1, 1150 cm?1, 1020 cm?1, 747 cm?1 and 702 cm?1 and Raman absorption spectra having characteristic peaks approximately at 3066 cm?1, 1583 cm?1, 1528 cm?1, 1281 cm?1, 1213 cm?1, 1035 cm?1, 1022 cm?1 and 1004 cm?1.
    Type: Application
    Filed: November 12, 2013
    Publication date: September 17, 2015
    Applicant: SHILPA MEDICARE LIMITED
    Inventors: Vimal Kumar Shrawat, Rafiuddin N/A, Vinod Singh, Akshay Kant Chaturvedi
  • Patent number: 9108924
    Abstract: The present invention relates to an improved process for the synthesis of bendamustine, in particular, bendamustine hydrochloride of the formula (VI) and its intermediate 1-methyl-5-[bis(2-chloroethyl)amino]-1H-benzimidazol-2-yl]lithium butanoate of formula (V), both having a purity of ?99%, which is simple, convenient, economical, does not use hazardous chemicals and is industrially viable.
    Type: Grant
    Filed: September 20, 2012
    Date of Patent: August 18, 2015
    Assignee: Fresenius Kabi Oncology Limited
    Inventors: Bhuwan Bhaskar Mishra, Nikunj Shambhubhai Kachhadia, Vinod Singh Tomar, Saswata Lahiri
  • Publication number: 20150105561
    Abstract: The present invention relates to an improved process for the synthesis of bendamustine, in particular, bendamustine hydrochloride of the formula (VI) and its intermediate 1-methyl-5-[bis(2-chloroethyl)amino]-1H-benzimidazol-2-yl]lithium butanoate of formula (V), both having a purity of ?99%, which is simple, convenient, economical, does not use hazardous chemicals and is industrially viable.
    Type: Application
    Filed: December 19, 2014
    Publication date: April 16, 2015
    Inventors: Bhuwan Bhaskar Mishra, Nikunj Shambhubhai Kachhadia, Vinod Singh Tomar, Saswata Lahiri
  • Publication number: 20140104080
    Abstract: A system and method for displaying a first intruder aircraft symbology on a lateral map display and on a vertical situation display is provided. Symbology is generated that is graphically representative of the first intruder aircraft on the lateral map display and the VSD. Additional symbology is generated to correlate the first intruder aircraft on the lateral map display to that on the vertical situation display.
    Type: Application
    Filed: October 12, 2012
    Publication date: April 17, 2014
    Applicant: HONEYWELL INTERNATIONAL INC.
    Inventors: Shivashankar Veerayya Maddanimath, Vinod Singh, Satish Pindikoor, Devesh Choubey
  • Publication number: 20060247285
    Abstract: The present invention relates to novel heterocyclic diphenyl ether and diphenyl amine compounds, derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts and pharmaceutically acceptable solvates thereof and pharmaceutically acceptable compositions containing these singly or in combination. The compounds of the present invention are effective in lowering blood glucose, serum insulin, free fatty acids, cholesterol and triglyceride levels and are useful in the treatment and/or prophylaxis of diabetes. The compounds of the present invention are effective in treatment of obesity, inflammation, autoimmune diseases such as multiple sclerosis and rheumatoid arthritis and immunological diseases, including the treatment of cancer. Furthermore, the compounds are useful for the treatment of disorders associated with insulin resistance.
    Type: Application
    Filed: February 21, 2006
    Publication date: November 2, 2006
    Inventors: Partha Neogi, Bishwajit Nag, Debendranath Dey, Abhijeet Nag, Birendra Bhattacharya, Vinod Singh, Surendradoss Jayakumar
  • Publication number: 20060014746
    Abstract: This invention relates to heteroaryl substituted fused bicyclic heteroaryl compounds, such as heteroaryl substituted imidazopyridines, imidazopyrazines, imidazopyridizines, imidazopyrimidines, and imidazothiazoles, which may be described by Formula I or Formula II: The invention is particularly related to such compounds that bind with high selectivity and high affinity to the benzodiazepine site of GABAA receptors. This invention also relates to pharmaceutical compositions comprising such compounds and to the use of such compounds in treatment of certain central nervous system (CNS) diseases. Processes for preparing compounds of Formula I and Formula II are disclosed. This invention also relates to the use of benzimidazoles, pyridylimidazoles and related bicyclic heteroaryl compounds of Formula I or Formula II in combination with one or more other CNS agents to potentiate the effects of the other CNS agents.
    Type: Application
    Filed: August 29, 2005
    Publication date: January 19, 2006
    Inventors: Alan Hutchison, George Maynard, Pamela Albaugh, Linghong Xie, Jun Yuan, Scott Mitchell, Vinod Singh, Manuka Ghosh, Guiying Li, Nian Liu
  • Patent number: 6936617
    Abstract: This invention relates to heteroaryl substituted fused bicyclic heteroaryl compounds, such as heteroaryl substituted imidazopyridines, imidazopyrazines, imidazopyridizines, imidazopyrimidines, and imidazothiazoles, which may be described by Formula I or Formula II: The invention is particularly related to such compounds that bind with high selectivity and high affinity to the benzodiazepine site of GABAA receptors. This invention also relates to pharmaceutical compositions comprising such compounds and to the use of such compounds in treatment of certain central nervous system (CNS) diseases. Processes for preparing compounds of Formula I and Formula II are disclosed. This invention also relates to the use of benzimidazoles, pyridylimidazoles and related bicyclic heteroaryl compounds of Formula I or Formula II in combination with one or more other CNS agents to potentiate the effects of the other CNS agents.
    Type: Grant
    Filed: July 12, 2002
    Date of Patent: August 30, 2005
    Assignee: Neurogen Corporation
    Inventors: Alan Hutchison, George Maynard, Pamela Albaugh, Linghong Xie, Jun Yuan, Scott Mitchell, Vinod Singh, Manuka Ghosh, Guiying Li, Nian Liu
  • Patent number: 6916819
    Abstract: This invention relates to benzimidazoles, pyridylimidazoles and related bicyclic heteroaryl compounds, all of which may be described by of Formula I The invention is particularly related to such compounds that bind with high selectivity and high affinity to the benzodiazepine site of GABAA receptors. This invention also relates to pharmaceutical compositions comprising such compounds and to the use of such compounds in treatment of certain central nervous system (CNS) diseases. Novel processes for preparing compounds of Formula I are disclosed. This invention also relates to the use of benzimidazoles, pyridylimidazoles and related bicyclic heteroaryl compounds of Formula I in combination with one or more other CNS agents to potentiate the effects of the other CNS agents. Additionally this invention relates to the use such compounds as probes for the localization of GABAA receptors in tissue sections.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: July 12, 2005
    Assignee: Neurogen Corporation
    Inventors: Guiying Li, John M. Peterson, Pamela Albaugh, Kevin S. Currie, Guolin Cai, Linda M. Gustavson, Kyungae Lee, Alan Hutchison, Vinod Singh, George D. Maynard, Jun Yuan, Ling Hong Xie, Manuka Ghosh, Nian Liu
  • Publication number: 20050085546
    Abstract: The present invention is related to compounds having general formula Z-OC (CRn1Rn2)—CO-Z wherein Z=OH or NH2 and n1=n2=1 to 8, useful for modulation of immune response by inducing differentiation of dendritic cells consisting novel class of amino acid derivatives (sulfonic acid/sulfate derivatives of naturally occurring amino acids, and their amides) of the general formula ZOC—CR3R4—CR2(NHR1)—COOH, ZOC—CR5R6—CR3R4—CR1(NHR2)—COOH, ZOC—CR7R8—CR5R6—CR3R4—CR1N2)—COOH wherein Z=OH or NH2; R1 to R8 denotes H, SO3H, or OSO3H. In addition, the dicarboxylic acids and their amides ZOC—(CH2)n—CR1R2—COOH, where Z=OH or NH2; and n=1, 2, 3. The groups R1/R2=H/SO3H or OSO3H or CH2—SO3H or CH2—OSO3H and vice versa. The factors also contain different divalent metal cations such as Mg, Ca and Zn.
    Type: Application
    Filed: December 31, 2003
    Publication date: April 21, 2005
    Applicant: Council of Scientific & Industrial Research
    Inventors: Anil Chatterji, Krishnamurthy Natarajan, Venkatasamy Manivel, Kanury Venkata Subba Rao, Parameswaran Subrayan, Vinod Singh, Ramasamy Anand, Ehrlich Desa
  • Publication number: 20050085547
    Abstract: The present invention is related to compounds having general formula Z-OC(CRn1Rn2)—CO-Z wherein Z=OH or NH2 and n1=n2=1 to 8, for modulation of immune response by differentiation dendritic cells consisting novel class of amino acid derivatives (sulfonic acid/sulfate derivatives of naturally occurring amino acids, and their amides) of the general formula ZOC—CR3R4—CR2(NHR1)—COOH, ZOC—CR5R6—CR3R4—C(NHR2)—COOH, ZOC—CR7R8—CR5R6—CR3R4—CR1(NHR2)—COOH wherein Z=OH or NH2; R1 to R8 denotes H, SO3H, or OSO3H. In addition, the dicarboxylic acids and their amides ZOC—(CH2)n—CR1R2—COOH, where Z=OH or NH2; and n=1, 2, 3. The groups R1/R2=H/SO3H or OSO3H or CH2—SO3H or CH2—OSO3H and vice versa. The factors also contain different divalent metal cations such as Mg, Ca and Zn.
    Type: Application
    Filed: December 31, 2003
    Publication date: April 21, 2005
    Applicant: Council of Scientific & Industrial Research
    Inventors: Anil Chatterji, Krishnamurthy Natarajan, Venkatasamy Manivel, Kanury Subba Rao, Parameswaran Subrayan, Vinod Singh, Ramasamy Anand, Ehrlich Desa
  • Publication number: 20050085537
    Abstract: This invention relates to a novel class of acidic amino acid/dicarboxylic acid derivatives (sulfonic acid/sulfate derivatives of naturally occurring amino acids and their amides) useful as inhibitors of osteoclastogenesis. The invention also provides methods of using the novel class of acidic amino acid/dicarboxylic acid derivatives of the general formula ZOC—(CRR)m—COOH, wherein: m=2, 3 or 4; Z is OH or NH2; one R in the compound is from the group consisting of SO3H, OSO3H, CH2—SO3H, CH2—OSO3H, and NHSO3H, and the remaining Rs are H or NH2, for inhibition of osteoclastogenesis.
    Type: Application
    Filed: December 30, 2003
    Publication date: April 21, 2005
    Applicant: Council of Scientific & Industrial Research
    Inventors: Kanury Rao, Mohan Wani, Venkatasamy Manivel, Parameswaran Subrayan, Vinod Singh, Ramasamy Anand, Ehrlich Desa, Gyan Mishra, Anil Chatterji
  • Publication number: 20030207885
    Abstract: This invention relates to heteroaryl substituted fused bicyclic heteroaryl compounds, such as heteroaryl substituted imidazopyridines, imidazopyrazines, imidazopyridizines, imidazopyrimidines, and imidazothiazoles, which may be described by Formula I or Formula II: 1
    Type: Application
    Filed: July 12, 2002
    Publication date: November 6, 2003
    Inventors: Alan Hutchison, George Maynard, Pamela Albaugh, Linghong Xie, Jun Yuan, Scott Mitchell, Vinod Singh, Manuka Ghosh, Guiying Li, Nian Liu
  • Publication number: 20030069257
    Abstract: This invention relates to benzimidazoles, pyridylimidazoles and related bicyclic heteroaryl compounds, all of which may be described by of Formula I 1
    Type: Application
    Filed: December 21, 2001
    Publication date: April 10, 2003
    Inventors: Guiying Li, John M. Peterson, Pamela Albaugh, Kevin S. Currie, Guolin Cai, Linda M. Gustavson, Kyungae Lee, Alan Hutchison, Vinod Singh, George D. Maynard, Jun Yuan, Ling Hong Xie, Manuka Ghosh, Nian Liu, George P. Luke, Scott Mitchell, Martin Patrick Allen, Spiros Liras